Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...
Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...
Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...
The partnership aims to broaden the range of support services available to individuals experiencing bladder control issues. Credit: Shidlovski / Shutterstock.com. Minze Health has reached an agreement ...
Patients with bladder control symptoms who receive a Medtronic Sacral Neuromodulation Device will now have access to the Minze Diary Pod Under this partnership, the Minze Diary Pod – an automated ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results